WallStreetZenWallStreetZen

NASDAQ: HBIO
Harvard Bioscience Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their HBIO stock forecasts and price targets.

Forecast return on equity

Is HBIO forecast to generate an efficient return?
Company
N/A
Industry
12.76%
Market
29.39%

Forecast return on assets

Is HBIO forecast to generate an efficient return on assets?
Company
N/A
Industry
7.28%

HBIO revenue forecast

What is HBIO's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$118.8M+5.84%
Avg 2 year Forecast
$135.0M+20.27%
HBIO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HBIO revenue growth forecast

How is HBIO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
5.84%
Industry
6.16%
Market
13.87%
HBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HBIO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
HBIO$4.20N/AN/A
INFU$8.80N/AN/A
STXS$2.51$4.50+79.28%Strong Buy
ANGO$5.70$15.00+163.16%Strong Buy
AKYA$4.73$8.75+84.99%Strong Buy

Harvard Bioscience Stock Forecast FAQ

What is HBIO's revenue growth forecast for 2024-2025?

(NASDAQ: HBIO) Harvard Bioscience's forecast annual revenue growth rate of 5.84% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.87%.

Harvard Bioscience's revenue in 2024 is $112,250,000.On average, 2 Wall Street analysts forecast HBIO's revenue for 2024 to be $5,155,835,771, with the lowest HBIO revenue forecast at $5,060,357,331, and the highest HBIO revenue forecast at $5,251,314,211.

In 2025, HBIO is forecast to generate $5,858,904,285 in revenue, with the lowest revenue forecast at $5,858,904,285 and the highest revenue forecast at $5,858,904,285.

If you're new to stock investing, here's how to buy Harvard Bioscience stock.

What is HBIO's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: HBIO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 7.28%.

What is HBIO's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: HBIO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.